Parthenogenetically activated human oocytes and parthenogenetic embryonic stem cells: US20100233143

Expert Opinion on Therapeutic Patents

Volumn 21, Issue 8, 2011, Pages 1281-1283

  Taupin, Philippe ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

ethic; induced pluripotent stem cells; parthenogenesis; regenerative medicine; therapy

Indexed keywords

IONOPHORE; PROTEIN SERINE THREONINE KINASE INHIBITOR;

ARTICLE; BLASTOCYST; CELL ISOLATION; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; INNER CELL MASS; OOCYTE; OXYGEN TENSION; PARTHENOGENESIS; PATENT;

CELL CULTURE TECHNIQUES; CELL SEPARATION; EMBRYONIC STEM CELLS; FEMALE; HUMANS; OOCYTES; PARTHENOGENESIS; PATENTS AS TOPIC;

EID: 79960692442     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2011.581230     Document Type: Article

References (16)

1. Taupin P. Derivation of embryonic stem cells for cellular therapy: challenges and new strategies. Med Sci Monit 2006;12:RA75-8
2. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA 1995;92:7844-8
3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7, Erratum in: Science 1998;282:1827
4. Taupin P. Stem cells engineering for cell-based therapy. J Neur Eng 2007;4:R59-63
5. Hao J, Zhu W, Sheng C, et al. Human parthenogenetic embryonic stem cells: one potential resource for cell therapy. Sci China C Life Sci 2009;52:599-602
6. Taupin P. Autologous transplantation in the central nervous system. Ind J Med Res 2006;124:613-18 (Pubitemid 46592101)
7. Pashaiasl M, Khodadadi K, Holland MK, et al. The efficient generation of cell lines from bovine parthenotes. Cell Reprogram 2010;12:571-9
8. Sumer H, Liu J, Tat P, et al. Somatic cell nuclear transfer: pros and cons. J Stem Cells 2009;4:85-93
9. Shi Y. Induced pluripotent stem cells, new tools for drug discovery and new hope for stem cell therapies. Curr Mol Pharmacol 2009;2:15-8
10. Taupin P. Adult neural stem cells, neurogenic niches and cellular therapy. Stem Cell Rev 2006;2:213-19
11. Taupin P. Very small embryonic-like stem cells for regenerative medicine: WO2010039241. Exp Opin Ther Patents 2010;20:1103-6
12. Huang J, Okuka M, Wang F, et al. Generation of pluripotent stem cells from eggs of aging mice. Aging Cell 2010;9:113-25
13. Brevini TA, Pennarossa G, deEguileor M, et al. Parthenogenetic cell lines: an unstable equilibrium between pluripotency and malignant transformation. Curr Pharm Biotechnol 2011;12:206-12
14. Taupin P. Stem cells from non-viable versus post-mortem tissues. Med Sci Monit 2007;13:LE1-1
15. Taupin P. Adult neurogenesis and neural stem cells as a model for the discovery and development of novel drugs. Expert Opin Drug Discov 2010;5:921-5
16. Taupin P. Adult neurogenesis, neural stem cells and Alzheimers disease: developments, limitations, problems and promises. Curr Alzheimer Res 2009;6:461-70